Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports one relevant journal, 2 Conferences, 3 workshops/Symposium are presently dedicated exclusively to auto immune diseases and about 1 article is being published on auto immune diseases.
A condition in which a person’s own immune system begins to attack the healthy organs and cells of his or her own body.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Currently, North America dominates the global autoimmune diseases treatment market, followed by Europe. The autoimmune disorders therapeutics market, comprising RA, MS, psoriasis, IBDs (CD and UC) and SLE, was worth $16.9 billion in 2002 and grew at a Compound Annual Growth Rate (CAGR) of 7.5% to $30.2 billion in 2010. It is forecast to reach $61.4 billion in 2017, indicating a CAGR of 10.7% during the forecast period. The average Annual Cost of Treatment (ACT) for autoimmune disorders therapeutics is increasing, and is expected to reach $12,073 by 2017, resulting in steady increase of the overall market during the forecast period. Growth in the major markets of the US, the top five countries of Europe, and Japan was driven by new developments that have created more treatment options for these indications. The future of the global market is therefore based on the success of the drugs in the pipeline.
Wider availability of biosimilar drugs and affordable treatment could open up opportunities for new players in the global autoimmune diseases treatment market. Moreover, safety and quality of autoimmune diseases controlling therapy could lead a challenge for the growth of the global autoimmune diseases treatment market.
International Conferences
Major Associations and Societies
This page will be updated regularly.
This page was last updated on November 5, 2024
